Literature DB >> 22534637

Atypical presentation of exophytic herpes simplex virus type 2 with concurrent cytomegalovirus infection: a significant pitfall in diagnosis.

George Garib1, Lauren C Hughey, Craig A Elmets, Jennifer A Cafardi, Aleodor A Andea.   

Abstract

We report 3 unusual cases of atypical exophytic cutaneous herpes simplex virus (HSV) type 2 with concurrent cytomegalovirus (CMV) infection in immunosuppressed patients and raise awareness to the significant clinical and pathologic challenges in establishing the correct diagnosis. In all the 3 cases, the lesions presented as fungating plaques and nodules with areas of superficial erosion. Initial clinical differential included genital warts, syphilis, versus cutaneous malignancy. All the 3 patients were referred to the dermatology clinic where a combination of cutaneous biopsies, viral cultures of the lesions, polymerase chain reaction, CMV antigenemia, and immunoperoxidase stains for CMV and HSV confirmed the diagnosis of HSV type 2 with concurrent CMV infection. All the 3 patients were treated with oral valganciclovir with significant improvement noted at the follow-up visit. In addition, we review the previously reported HSV/CMV cutaneous coinfection cases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22534637      PMCID: PMC3681094          DOI: 10.1097/DAD.0b013e3182539eee

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  10 in total

1.  Histopathologic findings in cutaneous cytomegalovirus infection.

Authors:  K S Resnik; M DiLeonardo; M Maillet
Journal:  Am J Dermatopathol       Date:  2000-10       Impact factor: 1.533

Review 2.  Diagnosis of cutaneous cytomegalovirus infection: a review and report of a case.

Authors:  B K Toome; K E Bowers; G A Scott
Journal:  J Am Acad Dermatol       Date:  1991-05       Impact factor: 11.527

Review 3.  Cytomegalovirus infection in normal and immunocompromised humans. A review.

Authors:  F Drago; M G Aragone; C Lugani; A Rebora
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

4.  Infectious complications in the renal transplant recipient.

Authors:  A Grimaldi; A Barletta; M Rascente; F Pisani; G Iaria; D Maccarone; E Maira; M D'Angelo; A Famulari
Journal:  Transplant Proc       Date:  2005 Jul-Aug       Impact factor: 1.066

5.  Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients.

Authors:  Y-L Choi; J-A Kim; K-T Jang; D-S Kim; W-S Kim; J-H Lee; J-M Yang; E-S Lee; D-Y Lee
Journal:  Br J Dermatol       Date:  2006-11       Impact factor: 9.302

Review 6.  Viral prophylaxis in organ transplant patients.

Authors:  Michelle Slifkin; Shira Doron; David R Snydman
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Concurrent cytomegalovirus and herpes simplex virus infections in skin biopsy specimens from two AIDS patients with fatal CMV infection.

Authors:  J Y Lee; R Peel
Journal:  Am J Dermatopathol       Date:  1989-04       Impact factor: 1.533

8.  Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years--United States, 2005-2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-04-23       Impact factor: 17.586

9.  Cutaneous manifestations of cytomegalovirus disease in renal transplant recipients: a case series.

Authors:  M O Kaisar; R M Kirwan; G M Strutton; C M Hawley; D W Mudge; S B Campbell; D W Johnson; N M Isbel
Journal:  Transpl Infect Dis       Date:  2007-09-10       Impact factor: 2.228

10.  Exophytic ulcerated tumors in HIV patients: diagnostic and therapeutic problems.

Authors:  Stephan Lautenschlager; Stefan Schwarzkopf; Beat Keller
Journal:  Dermatology       Date:  2008       Impact factor: 5.366

  10 in total
  1 in total

1.  Cutaneous Co-infected Cytomegalovirus and Herpes Simplex Virus Perigenital Ulcers in Human Immunodeficiency Virus Patients.

Authors:  Jason Schoenfeld; Sarah Cannon; Kristin Cam; Matthew Keller
Journal:  J Clin Aesthet Dermatol       Date:  2013-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.